Psychiatry · Madison, AL
NPI
1720044076
Since 2006
Specialty
Psychiatry
Code 2084P0800X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
708 Will Halsey Way Ste C
Madison, AL, 35758
Phone (256) 325-1349
Groups this clinician bills Medicare through
Medicare paid, 2024
$137K
2,398 services
Medicare patients, 2024
265
Average age 64
Drug cost, 2024
$856K
8,581 prescriptions
Company payments, 2025
$2,263
From 19 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ammar Alrefai was code 90833 (psychotherapy - nongroup), 874 times for 259 patients. In total Ammar Alrefai billed 2,398 services in 10 codes, and Medicare paid $137K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-11-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 90833 Psychotherapy - Nongroup | Office | 874 | 259 | $39.35 | $34K |
| 99214 Office E&M - Established | Office | 855 | 254 | $58.98 | $50K |
| 99213 Office E&M - Established | Office | 16 | 13 | $44.22 | $708 |
| 90792 Psychotherapy - Nongroup | Office | 15 | 12 | $99.39 | $1,491 |
By year: 2022 $286K for 4,091 services; 2023 $269K for 4,124 services; 2024 $137K for 2,398 services.
Medicare prescription drug claims, 2024
In 2024, the drug Ammar Alrefai prescribed most often to Medicare patients was Clonazepam, with 1,002 prescriptions and refills. In total Ammar Alrefai wrote 8,581 Medicare prescriptions that cost $856K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Clonazepam Generic | 1,002 | 1,120 | 152 | $7,520 |
| Alprazolam Generic | 603 | 661 | 99 | $3,173 |
| Dextroamphetamine-Amphetamine Dextroamphetamine/Amphetamine | 492 | 496 | 68 | $15K |
| Lorazepam Generic | 401 | 419 | 70 | $2,955 |
| Quetiapine Fumarate Generic | 355 | 518 | 80 | $4,711 |
| Gabapentin Generic | 335 | 377 | 45 | $2,977 |
| Bupropion Xl Bupropion Hcl | 320 | 510 | 70 | $6,507 |
| Trazodone Hcl Generic | 255 | 409 | 77 | $2,425 |
| Dextroamphetamine-Amphet Er Dextroamphetamine/Amphetamine | 254 | 254 | 35 | $14K |
| Diazepam Generic | 252 | 252 | 39 | $1,386 |
| Zolpidem Tartrate Generic | 250 | 292 | 48 | $1,254 |
| Fluoxetine Hcl Generic | 220 | 308 | 48 | $1,821 |
| Buspirone Hcl Generic | 218 | 273 | 50 | $1,813 |
| Duloxetine Hcl Generic | 198 | 296 | 52 | $4,315 |
| Lamotrigine Generic | 157 | 284 | 44 | $1,853 |
Brand drugs: 462 claims; generic drugs: 8,119 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ammar Alrefai $2,263 ($2,263 in general payments such as food, travel and fees) from 19 companies. The largest payer was Alkermes, Inc. with $404.
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. ALKS | 16 | $404 |
| Abbvie Inc. ABBV | 23 | $325 |
| Neurocrine BioSciences, Inc. NBIX | 12 | $323 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 13 | $251 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 7 | $150 |
| Indivior Inc. INDV | 4 | $129 |
| Corium, LLC | 5 | $108 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 5 | $97.94 |
| Teva Pharmaceuticals USA, Inc. TEVA | 4 | $85.09 |
| Axsome Therapeutics, Inc. AXSM | 4 | $65.34 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.